Juan José Borrero Martín

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip et al. · Annals of Oncology · 2015 · 104 citations · Full text

Elderly Patients, Gastrointestinal Oncology, Medicine +8

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma

María C. Ferrufino‐Schmidt, L. Jeffrey Medeiros, Hui Liu et al. · The American Journal of Surgical Pathology · 2017 · 94 citations · Full text

Surgical Oncology, Breast Oncology, Lymph Node Involvement +16

Expression of hpttg proto-oncogene in lymphoid neoplasias

Carmen Sáez, Teresa Pereda, Juan José Borrero Martín et al. · Oncogene · 2002 · 41 citations

Hpttg Proto-oncogene, Tumor Biology, Lymphoid Neoplasia +6

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

Thomas Aparicio, Michel Ducreux, Roger Faroux et al. · European Journal of Cancer · 2018 · 39 citations · Full text

Obesity, Ffcd Trials, Gastrointestinal Oncology +9

Plasmablastic lymphoma of the oral cavity and jaws

Juan José Borrero Martín, Emilio Pujol, Sofı́a Pérez et al. · AIDS · 2002 · 26 citations

Immunodeficiencies, Immunology, Plasmablastic Lymphoma +19